Reinsurance Group of America, Incorporated provides reinsurance and financial solutions. It offers individual and group life and health insurance products, such as term life, credit life, universal life, whole life, group life and health, joint and last survivor insurance, critical illness, disability, and longevity products, as well as asset-intensive and financial reinsurance products; and other capital motivated solutions. The company also provides reinsurance for mortality, morbidity, lapse, and investment-related risk associated with products; and reinsurance for investment-related risks. In addition, the company develops and markets technology solutions; and offers consulting and outsourcing solutions for the insurance and reinsurance industries. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. Reinsurance Group of America, Incorporated was founded in 1973 and is headquartered in Chesterfield, Missouri.
Global Reinsurance Giant | Reinsurance Group of America (RGA) stands as a formidable player in the global life reinsurance market, boasting a market cap of $14.78 billion and robust financial health. |
Earnings Power Unleashed | Discover RGA's impressive 22.08% revenue growth and upward earnings revisions, signaling strong financial performance and market confidence in its growth trajectory. |
Strategic Diversification | Explore RGA's success in international markets, particularly Asia, and its strategic focus on high-growth sectors like Pension Risk Transfer and longevity business. |
Future-Focused Outlook | Analysts project EPS of 20.46 for FY2025 and 23.28 for FY2026, with price targets ranging from $235 to $250, reflecting optimism about RGA's market position and growth potential. |
Metrics to compare | RGA | Sector Sector - Average of metrics from a broad group of related Financial sector companies | Relationship RelationshipRGAPeersSector | |
---|---|---|---|---|
P/E Ratio | 17.0x | 9.7x | 8.5x | |
PEG Ratio | −0.83 | 0.23 | 0.03 | |
Price/Book | 1.1x | 1.4x | 1.0x | |
Price / LTM Sales | 0.6x | 1.0x | 2.6x | |
Upside (Analyst Target) | 34.1% | 19.5% | 22.2% | |
Fair Value Upside | Unlock | 3.1% | 4.4% | Unlock |